Literature DB >> 37867

Quantitative assessment of bronchial beta-adrenoceptor blockade in man.

H R Gribbin, C J Baldwin, A E Tattersfield.   

Abstract

1. We describe a method for assessing bronchial beta-adrenoceptor blockade quantitatively in man. Specific airway conductance is measured after increasing doses of inhaled salbutamol and the extent to which the dose-response curve is displaced to the right after beta-adrenoceptor blocking drugs is used to assess bronchial beta-adrenoceptor blockade. 2. Salbutamol dose-response curves were plotted for six normal subjects by measuring sGaw 15 min after increasing doses of inhaled salbutamol. Salbutamol produced a 30-70% increase in sGaw. 3. Salbutamol dose response curves were obtained 2 h after oral practolol (100 mg and 200 mg) and oral propranolol (40 mg and 80 mg) on separate days and were displaced to the right. 4. The mean dose ratios for practolol 100 mg and 200 mg were 1.2 and 2.1 and for propranolol 40 mg and 80 mg they were 21 and 61 respectively.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 37867      PMCID: PMC1429682          DOI: 10.1111/j.1365-2125.1979.tb04641.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  24 in total

Review 1.  Bronchial hyperreactivity.

Authors:  M K Benson
Journal:  Br J Dis Chest       Date:  1975-10

2.  EFFECT OF A BETA-ADRENERGIC-BLOCKING AGENT, PROPRANOLOL, ON ASTHMATICS.

Authors:  R S MCNEILL
Journal:  Lancet       Date:  1964-11-21       Impact factor: 79.321

3.  A rapid plethysmographic method for measuring thoracic gas volume: a comparison with a nitrogen washout method for measuring functional residual capacity in normal subjects.

Authors:  A B DUBOIS; S Y BOTELHO; G N BEDELL; R MARSHALL; J H COMROE
Journal:  J Clin Invest       Date:  1956-03       Impact factor: 14.808

4.  Comparison of effects of metoprolol and propranolol on asthmatic airway obstruction.

Authors:  C Skinner; J Gaddie; K N Palmer
Journal:  Br Med J       Date:  1976-02-28

5.  beta-Adrenoceptor antagonists and respiratory function.

Authors:  D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1978-02       Impact factor: 4.335

6.  Studies of cardioselectivity and partial agonist activity in beta-adrenoceptor blockade comparing effects on heart rate and peak expiratory flow rate during exercise.

Authors:  V M Oh; C M Kaye; S J Warrington; E A Taylor; J Wadsworth
Journal:  Br J Clin Pharmacol       Date:  1978-02       Impact factor: 4.335

7.  Clinical assessment of bronchodilator drugs delivered by aerosol.

Authors:  G M Shenfield; J W Paterson
Journal:  Thorax       Date:  1973-03       Impact factor: 9.139

8.  The selectivity of beta-adrenoceptor antagonists on cardiovascular and bronchodilator responses to isoprenaline in the anaesthetized dog.

Authors:  M J Daly; J J Flook; G P Levy
Journal:  Br J Pharmacol       Date:  1975-02       Impact factor: 8.739

9.  The beta-adrenoceptor of the human lymphocyte and human lung parenchyma.

Authors:  M E Conolly; J K Greenacre
Journal:  Br J Pharmacol       Date:  1977-01       Impact factor: 8.739

10.  A new method for measuring airway resistance in man using a body plethysmograph: values in normal subjects and in patients with respiratory disease.

Authors:  A B DUBOIS; S Y BOTELHO; J H COMROE
Journal:  J Clin Invest       Date:  1956-03       Impact factor: 14.808

View more
  22 in total

1.  A comparison of lung function methods for assessing dose-response effects of salbutamol.

Authors:  Catherine M Houghton; Ashley A Woodcock; Dave Singh
Journal:  Br J Clin Pharmacol       Date:  2004-08       Impact factor: 4.335

2.  Comparative beta-adrenoceptor blocking effects of propranolol, bisoprolol, atenolol, acebutolol and diacetolol on the human isolated bronchus.

Authors:  E Naline; B Sarria; O Ertzbischoff; P Ozanne; C Advenier
Journal:  Br J Clin Pharmacol       Date:  1990-07       Impact factor: 4.335

3.  Evaluation of the metabolic responses to inhaled salbutamol in the measurement of beta 2-adrenoceptor blockade.

Authors:  B J Lipworth; L C McFarlane; W J Coutie; D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

4.  Assessment of airways, tremor and chronotropic responses to inhaled salbutamol in the quantification of beta 2-adrenoceptor blockade.

Authors:  B J Lipworth; R A Brown; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1989-07       Impact factor: 4.335

Review 5.  Which beta blocker?

Authors:  A Breckenridge
Journal:  Br Med J (Clin Res Ed)       Date:  1983-04-02

Review 6.  Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia.

Authors:  B N Singh; W R Thoden; A Ward
Journal:  Drugs       Date:  1985-06       Impact factor: 9.546

7.  Airway response to inhaled salbutamol in hyperthyroid and hypothyroid patients before and after treatment.

Authors:  R N Harrison; A E Tattersfield
Journal:  Thorax       Date:  1984-01       Impact factor: 9.139

8.  The influence of theophylline on maximal response to salbutamol in severe chronic obstructive pulmonary disease.

Authors:  J Barclay; B Whiting; G J Addis
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

9.  Effect of ICI 118551 on bronchial beta-adrenoceptor function and exercise heart rate in normal man.

Authors:  A E Tattersfield; D J Cragg
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

10.  Assessment of beta-adrenoceptor selectivity of a new beta-adrenoceptor antagonist, bisoprolol, in man.

Authors:  A E Tattersfield; D J Cragg; R J Bacon
Journal:  Br J Clin Pharmacol       Date:  1984-09       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.